Tourette Syndrome Clinical Trial
— InSPSCTSOfficial title:
Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome
NCT number | NCT04449003 |
Other study ID # | U11234 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | March 29, 2021 |
Est. completion date | February 10, 2023 |
Verified date | February 2023 |
Source | Vanderbilt University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Investigators propose a cross-sectional, observational pilot study to examine the contribution of stress, family dynamics, and peer relationships to quality of life (QOL) in adolescents with Tourette syndrome (TS). Investigators will recruit two groups of participants: 1) adolescents aged 13-17 years of age with TS and 2) adolescents aged 13-17 without any neurologic or psychiatric diagnoses. Participants and one of their parents/caregivers will complete a series of questionnaires screening for and quantifying the extent of stress and mental health symptoms, including anxiety, depression, obsessive compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD). Participants will also complete instruments characterizing family interactions and peer relationships. Adolescents with TS will also undergo a semi-structured interview assessing the severity of their tics.
Status | Completed |
Enrollment | 66 |
Est. completion date | February 10, 2023 |
Est. primary completion date | December 28, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 13 Years to 17 Years |
Eligibility | Inclusion Criteria for adolescents with TS: - adolescent age 13-17 years of age - adolescent diagnosis of Tourette syndrome (TS) - English-speaking adolescent and caregiver (as validated questionnaires are in English) - adolescent and caregiver willingness and ability to complete relevant questionnaires Exclusion Criteria for adolescents with TS: - cognitive or attentional impairment precluding ability of adolescent or caregiver to complete self-report questionnaires - adolescent diagnosis of genetic conditions besides TS and its known comorbidities - adolescent with severe medical conditions unrelated to TS (e.g. uncontrolled seizures, prominent heart conditions) Inclusion Criteria for adolescents without any neurologic or psychiatric diagnoses: - adolescent age 13-17 years of age - no history of tics - English-speaking adolescent and caregiver - adolescent and caregiver willingness and ability to complete relevant questionnaires Exclusion Criteria for adolescents without any neurologic or psychiatric diagnoses: - cognitive or attentional impairment precluding ability of adolescent or caregiver to complete self-report questionnaires - adolescent with severe medical conditions |
Country | Name | City | State |
---|---|---|---|
United States | Vanderbilt University Medical Center | Nashville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
Vanderbilt University Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Youth Quality of Life Research Version (YQOL-R) | Self-report quality of life scale comprised of 42 items with 10-point Likert scale (raw total score 0-420) and 15 additional items with open-ended and demographic questions. Higher scores indicate better overall quality of life. | Baseline | |
Secondary | Cohen's Perceived Stress Scale | Self-report stress scale comprised of 10 items (total score range 0-40). Higher scores indicate greater perceived stress. | Baseline | |
Secondary | PedsQL - Family Impact Module | Caregiver-report scale comprised of 36 items (total score range 0-100) assessing impact of health condition(s) on family. Higher scores indicate better family functioning in context of health-related condition(s). | Baseline | |
Secondary | Conners-3 Parent Short QuikScore Forms | Caregiver-report scale comprised of 45 items assessing inattention, hyperactivity, and executive functioning of child. T-scores are generated, with higher scores indicating greater deviation from norms. | Baseline | |
Secondary | Revised Children's Anxiety and Depression Scale (RCADS) - Parent Report | Caregiver-report scale comprised of 47 items assessing mood symptoms. T-scores are generated, with higher scores indicating greater deviation from norms. | Baseline | |
Secondary | Revised Children's Anxiety and Depression Scale (RCADS) - Self-Report | Self-report scale comprised of 47 items assessing mood symptoms. T-scores are generated, with higher scores indicating greater deviation from norms. | Baseline | |
Secondary | Yale Global Tic Severity Scale (YGTSS) | Semi-structured clinician-administered interview assessing tic severity, with total tic score range of 0-50 and functional impairment scale range of 0-50. Higher scores indicate greater tic severity and functional impairment, respectively. This measure will only be administered to adolescents with TS. | Baseline | |
Secondary | School and Mental Health Services Inventory | Questionnaire assessing educational and functional status of child. No total score generated. | Baseline | |
Secondary | Rosenberg Self Esteem Scale | Self-report self-esteem scale comprised of 10 items (total score range 10-40). Higher scores indicate higher self-esteem. | Baseline | |
Secondary | Kearney's Daily Life Stressors Scale | Self-report scale consisting of 30 items (total score range 0-120) assessing degree of stress caused by daily activities. Higher scores indicate greater burden from daily stressors. | Baseline | |
Secondary | McMaster Family Assessment Device | Self-report scale consisting of 60 items (total score range 0-180) assessing structural, organizational, and interactional aspects of family environment. The scale contains subscales, the scores of which are added to create a composite overall score, with higher scores indicative of more supportive family environment. | Baseline | |
Secondary | PROMIS Peer Relationships Short Form 8a - Self Report | Self-report scale consisting of 8 items (total score is composite of individual item scores, ranked on Likert scale from 1-5) assessing quality of peer relationships. Total raw scores are converted to a T-score. Higher scores indicate more positive perception of peer relationships. | Baseline | |
Secondary | PROMIS Peer Relationships Short Form 8a - Proxy-Report | Proxy-report scale consisting of 8 items (total score is composite of individual item scores, ranked on Likert scale from 1-5) assessing quality of child's peer relationships. Total raw scores are converted to a T-score. Higher scores indicate more positive perception of child peer relationships. | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04851678 -
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
|
||
Completed |
NCT02605902 -
Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders
|
N/A | |
Completed |
NCT04007913 -
Incorporating teleCBIT Into a Hospital-Based Tic Program
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Completed |
NCT02216474 -
Brain Stimulation in Movement Disorders
|
N/A | |
Completed |
NCT02256475 -
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT01329198 -
Brain Stimulation for the Treatment of Tourette Syndrome
|
N/A | |
Terminated |
NCT00952601 -
Pilot Study of the Modified Atkins Diet for Tourette Syndrome
|
Phase 1 | |
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00206323 -
A Randomized, Placebo-controlled, Tourette Syndrome Study.
|
Phase 3 | |
Completed |
NCT00004376 -
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
|
Phase 3 | |
Completed |
NCT04498364 -
Extinction Learning in Adults With Tourette Syndrome
|
N/A | |
Completed |
NCT00755339 -
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
|
||
Completed |
NCT03325010 -
Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Completed |
NCT01719523 -
Open-Trial of EPI-743 for Adults With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT01702077 -
Neurofeedback for Tourette Syndrome
|
N/A | |
Completed |
NCT00231985 -
Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder
|
Phase 2 | |
Completed |
NCT00206336 -
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
|
Phase 3 | |
Terminated |
NCT03732534 -
Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
|
Phase 2 |